
Thinking critically about evidence and ethics in psychiatry.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 9 | Subscribers | Read | thinkingpsychiatry.substack.com |
Curious about how many subscribers Thinking Psychiatry has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Recent posts by this newsletter. Browse the email archive.
In March 2024, the FDA cleared the NeuroStar transcranial magnetic stimulation (TMS) device “as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (age 15-21).” This clearance was widely celebrated. A glo...
A previous post evaluated the first SAINT TMS protocol clinical trial, where I raised concerns about the tiny sample, unusual outcome measures, risk of effective unblinding, and missing data for blinding integrity. I was worried that the hy...
I’ve been reading more TMS trials recently. Today, I’ll focus on the first SAINT protocol RCT published in 2021—probably the single most famous and influential TMS study. A subsequent post will look at the replication RCT just published in ...
This may be a particularly nerdy post. But it’s important. Aripiprazole (branded Abilify) augmentation has become a major treatment strategy for difficult-to-treat depression. Two large clinical trials suggest that aripiprazole augmentation...
Other publications recommended by the authors of this newsletter.
The writers behind this newsletter.
I am an academic psychiatrist trying to improve the quality of evidence in psychiatry. I'm in favor of humility and against hype and bad science. All views my own.
You can find recent issues that have been published by Thinking Psychiatry on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Thinking Psychiatry, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Thinking Psychiatry as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Thinking Psychiatry using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like Thinking Psychiatry. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.